JP5435955B2 - 安定な酵素製剤及びその使用方法 - Google Patents
安定な酵素製剤及びその使用方法 Download PDFInfo
- Publication number
- JP5435955B2 JP5435955B2 JP2008548072A JP2008548072A JP5435955B2 JP 5435955 B2 JP5435955 B2 JP 5435955B2 JP 2008548072 A JP2008548072 A JP 2008548072A JP 2008548072 A JP2008548072 A JP 2008548072A JP 5435955 B2 JP5435955 B2 JP 5435955B2
- Authority
- JP
- Japan
- Prior art keywords
- buffer
- solution
- composition
- kit
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75340005P | 2005-12-27 | 2005-12-27 | |
| US60/753,400 | 2005-12-27 | ||
| PCT/IL2006/001492 WO2007074454A2 (en) | 2005-12-27 | 2006-12-27 | Stable enzymatic preparations and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009521521A JP2009521521A (ja) | 2009-06-04 |
| JP2009521521A5 JP2009521521A5 (cg-RX-API-DMAC7.html) | 2010-02-12 |
| JP5435955B2 true JP5435955B2 (ja) | 2014-03-05 |
Family
ID=37943776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008548072A Expired - Fee Related JP5435955B2 (ja) | 2005-12-27 | 2006-12-27 | 安定な酵素製剤及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8197808B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1965763B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5435955B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1965763T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2763724T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007074454A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
| US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
| US8197808B2 (en) | 2005-12-27 | 2012-06-12 | Ramot At Tel-Aviv University Ltd. | Stable enzymatic preparations and methods of use thereof |
| CN101588803B (zh) * | 2006-12-06 | 2013-03-20 | 康乃尔研究基金会有限公司 | 中等持续时间神经肌肉阻断剂及其拮抗剂 |
| US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
| US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
| WO2009152374A2 (en) | 2008-06-12 | 2009-12-17 | Medtronic Xomed, Inc. | Method for treating chronic wounds |
| US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
| PL2318035T3 (pl) | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
| US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
| CA2747703C (en) | 2009-01-06 | 2021-06-15 | Curemark Llc | Compositions and methods for the treatment or the prevention of infections by e. coli |
| JP5684725B2 (ja) | 2009-01-06 | 2015-03-18 | キュレロン リミテッド ライアビリティ カンパニー | 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法 |
| EP2226382A1 (en) | 2009-03-03 | 2010-09-08 | B.R.A.I.N. Biotechnology Research and Information Network AG | Protease for wound conditioning and skin care |
| US8592451B2 (en) | 2009-03-17 | 2013-11-26 | Cornell University | Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
| US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| WO2011022491A1 (en) * | 2009-08-19 | 2011-02-24 | Cornell University | Cysteine for physiological injection |
| US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
| SG187534A1 (en) | 2010-08-29 | 2013-03-28 | Vascode Technologies Ltd | A system and methods for multi-tasking in a clientless mobile phone |
| DK2701733T3 (da) | 2011-04-21 | 2019-05-27 | Curemark Llc | Forbindelser til behandling af neuropsykiatriske forstyrrelser |
| JP5967675B2 (ja) * | 2011-08-31 | 2016-08-10 | ケーシーアイ ライセンシング インコーポレイテッド | 減圧治療および創面切除用のシステムおよび方法 |
| US20130202581A1 (en) * | 2012-02-02 | 2013-08-08 | Curelon Llc | Enzyme compositions and use thereof for wound healing |
| US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
| US11364286B2 (en) * | 2015-10-14 | 2022-06-21 | Newsouth Innovations Pty Limited | Compositions and methods for the treatment of diseases involving mucin |
| CA3012299C (en) * | 2016-01-31 | 2022-05-31 | Mediwound Ltd. | Debriding composition for treating wounds |
| NZ748416A (en) * | 2016-04-18 | 2022-12-23 | Mediwound Ltd | Methods of debridement of chronic wounds |
| WO2018191233A1 (en) | 2017-04-10 | 2018-10-18 | Curemark, Llc | Compositions for treating addiction |
| US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
| CA3199921A1 (en) * | 2020-11-25 | 2022-06-02 | Steven M. Hernandez | Scar treatment composition |
| CN115998690B (zh) * | 2022-11-10 | 2024-07-26 | 上海泰昶生物技术有限公司 | 包含免疫球蛋白g降解酶的冻干制剂及其制备工艺 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB913203A (en) | 1958-12-30 | 1962-12-19 | Swift & Co | Enzyme formulations for the production of tenderized meat |
| US3539451A (en) | 1968-05-31 | 1970-11-10 | Castle & Cooke | Production of reversibly inactivated papain and ficin |
| US4307081A (en) | 1974-01-08 | 1981-12-22 | Gerold K. V. Klein | Enzyme mixture |
| US4715899A (en) | 1982-10-21 | 1987-12-29 | Subir Chanda | Liquid cleaner containing inactivated protease for protein soiled contact lenses |
| JPH0449299A (ja) | 1990-06-14 | 1992-02-18 | Tosoh Corp | 免疫グロブリンフラグメントの精製法 |
| DE4026591B4 (de) | 1990-08-23 | 2005-08-25 | Pleva Gmbh | Vorrichtung zur Bestimmung der Beladung von Luft mit Dämpfen |
| JP2665639B2 (ja) | 1992-01-09 | 1997-10-22 | テーオー食品株式会社 | 安定化されたチオール蛋白分解酵素を含む焼き肉のタレ |
| US7364565B2 (en) | 2001-07-27 | 2008-04-29 | Ramot At Tel Aviv University Ltd. | Controlled enzymatic removal and retrieval of cells |
| EP1446096A1 (en) | 2001-11-13 | 2004-08-18 | The Procter & Gamble Company | Topical compositions containing enzymes stabilised with inhibitors |
| US6692726B1 (en) * | 2003-02-11 | 2004-02-17 | Colgate Palmolive Company | Enzyme containing oral composition having enhanced stability |
| DE602004020910D1 (de) | 2003-10-10 | 2009-06-10 | Cosmedical Aps | Haarwuchshemmung |
| US8197808B2 (en) | 2005-12-27 | 2012-06-12 | Ramot At Tel-Aviv University Ltd. | Stable enzymatic preparations and methods of use thereof |
-
2006
- 2006-12-27 US US12/087,108 patent/US8197808B2/en not_active Expired - Fee Related
- 2006-12-27 ES ES06821673T patent/ES2763724T3/es active Active
- 2006-12-27 DK DK06821673.8T patent/DK1965763T3/da active
- 2006-12-27 JP JP2008548072A patent/JP5435955B2/ja not_active Expired - Fee Related
- 2006-12-27 EP EP06821673.8A patent/EP1965763B1/en not_active Not-in-force
- 2006-12-27 WO PCT/IL2006/001492 patent/WO2007074454A2/en not_active Ceased
-
2012
- 2012-01-16 US US13/350,846 patent/US8337837B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007074454A3 (en) | 2007-09-20 |
| US20090220483A1 (en) | 2009-09-03 |
| US8337837B2 (en) | 2012-12-25 |
| US8197808B2 (en) | 2012-06-12 |
| EP1965763B1 (en) | 2019-11-06 |
| ES2763724T3 (es) | 2020-05-29 |
| DK1965763T3 (da) | 2020-02-10 |
| JP2009521521A (ja) | 2009-06-04 |
| US20120114631A1 (en) | 2012-05-10 |
| WO2007074454A2 (en) | 2007-07-05 |
| EP1965763A2 (en) | 2008-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8337837B2 (en) | Stable enzymatic preparations and methods of use thereof | |
| IL192483A (en) | Distribution tool for single use | |
| JP7853845B2 (ja) | Efpの治療または低減方法 | |
| Monafo et al. | Topical therapy for burns | |
| AU603567B2 (en) | Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith | |
| CA2071827C (en) | A treatment system for wounds and other disorders and a method for treating wounds and other skin disorders | |
| US8343515B2 (en) | Perfluorocarbon gel formulations | |
| US11045432B2 (en) | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | |
| KR101514414B1 (ko) | 당뇨병성 족부 궤양의 치료방법 | |
| US20080020025A1 (en) | Composition for wound care and method of using same | |
| CN102223877A (zh) | 全氟化碳凝胶 | |
| ES2785999T3 (es) | Composición para su uso en la preparación de un paciente para cirugía | |
| EP2877188B1 (en) | Preparation for treatment of wounds and sores comprising hypochlorite and amino acids | |
| AU2017315757A1 (en) | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | |
| CA2248177A1 (en) | Use of protealytic enzymes in the treatment of insect bites | |
| US9370533B2 (en) | Wound healing compositions comprising microspheres | |
| UA64801C2 (uk) | Склад з антисептичними, репаративними та болезаспокійливими властивостями | |
| RU2649785C1 (ru) | Антисептическая композиция, содержащая поливинилпирролидон и унитиол, применение такой композиции и способ обработки ран с ее использованием | |
| Burba | Traumatic foot injuries in horses: surgical management | |
| US20200297649A1 (en) | Devices and methods for delivery of oxygen to a wound | |
| WO2007143586A2 (en) | Composition for wound care and method of using same | |
| Elmenshawy et al. | Successful management after ingestion of a potentially fatal dose of inorganic mercuric chloride: A case report | |
| RU2239438C1 (ru) | Средство для лечения болезней суставов | |
| Mang et al. | Tumescent Technique in Aesthetic Plastic Surgery with Low Doses of Prilocaine Solution, Part I | |
| JP2693961B2 (ja) | 創傷の治癒のための二段階方法及びそれらに使用される水性媒体及び局所性軟膏 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080627 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091217 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120313 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120521 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120528 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120912 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130430 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130710 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131129 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131210 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5435955 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |